|Title||Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Chen Y, White RS, Tangel V, Noori SA, Gaber-Baylis LK, Mehta ND, Pryor KO|
|Journal||J Comp Eff Res|
|Date Published||2019 Apr|
AIM: To compare readmission rates between patients with sickle cell disease (SCD) and non-sickle cell disease undergoing total hip and knee arthroplasty (THA and TKA).
METHODS: Identified adult patients who underwent THA or TKA from 2007 to 2014 in California, Florida, New York, Maryland and Kentucky using a multistate database. Outcomes were 30- and 90-day readmission rates, mortality, complications, length of stay and hospital charges. Logistic regression models were used for analysis.
RESULTS: Compared with non-sickle cell disease patients following TKA and THA, SCD patients had higher odds of 30- (odds ratio [OR]: 3.79) and 90-day readmissions (OR: 4.15), mortality (OR: 6.54), more complications, longer length of stay, and higher total charges.
CONCLUSION: Following TKA and THA, SCD is associated with higher readmissions and worse outcomes.
|Alternate Journal||J Comp Eff Res|